Molecular basis of diverse ligand recognition and species-specific pharmacology at the complement anaphylatoxin receptor C3aR

The complement anaphylatoxin receptor, C3aR, is a prototypical G protein-coupled receptor (GPCR) that plays multi-faceted roles in immune regulation, pro-inflammatory responses, neuroimmune modulation, and host defense mechanisms against pathogens. Recent structural coverage has provided important insights into C3aR activation and signaling, however, confounding observations in the literature related to ligand efficacy and functional responses present a major challenge for drug discovery efforts. Here, we systematically and comprehensively profile a broad set of natural and synthetic ligands at C3aR, and demonstrate functional specialization in terms of species-specific pharmacology, receptor activation, and signaling-bias. Taking a lead from this, we determine seven cryo-EM structures of C3aR, and employ structure-guided site-directed mutagenesis studies to decode a convergent molecular mechanism that orchestrates the recognition and efficacy of diverse agonists. This study elucidates key molecular insights into C3aR activation and signaling with direct implications for therapeutic design. The complement anaphylatoxin receptor, C3aR is a potential drug target in various inflammatory disorders. Here, authors present insights into its activation, signaling, and pharmacology that is likely to facilitate therapeutic design going forward.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-08-25
DOI
https://doi.org/10.1038/s41467-026-76518-z
Primary Topic
Complement system in diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Molecular basis of diverse ligand recognition and species-specific pharmacology at the complement anaphylatoxin receptor C3aR

Cedric S. Cui, Jenny N. Fung, Parishmita Sarma, Osamu Nureki et al.
Nature Communications
Complement system in diseases
article

Molecular basis of diverse ligand recognition and species-specific pharmacology at the complement anaphylatoxin receptor C3aR

Cedric S. Cui, Jenny N. Fung, Parishmita Sarma, Osamu Nureki, Manisankar Ganguly, Cornelius Gati, Richard J. Clark, K. Sawada, Xaria X. Li, Ramanuj Banerjee, Nilanjana Banerjee, Trent M. Woodruff, Htet A. Khant, Fumiya K. Sano, Nabarun Roy, Ravi Yadav, Arun K. Shukla, John D. Lee, Jianina Marallag, Houming Zhu, Divyanshu Tiwari, Annu Dalal, Sudha Mishra, Calvin A. Dsouza, Manish K. Yadav, Ganita Rawat
article en

Abstract

The complement anaphylatoxin receptor, C3aR, is a prototypical G protein-coupled receptor (GPCR) that plays multi-faceted roles in immune regulation, pro-inflammatory responses, neuroimmune modulation, and host defense mechanisms against pathogens. Recent structural coverage has provided important insights into C3aR activation and signaling, however, confounding observations in the literature related to ligand efficacy and functional responses present a major challenge for drug discovery efforts. Here, we systematically and comprehensively profile a broad set of natural and synthetic ligands at C3aR, and demonstrate functional specialization in terms of species-specific pharmacology, receptor activation, and signaling-bias. Taking a lead from this, we determine seven cryo-EM structures of C3aR, and employ structure-guided site-directed mutagenesis studies to decode a convergent molecular mechanism that orchestrates the recognition and efficacy of diverse agonists. This study elucidates key molecular insights into C3aR activation and signaling with direct implications for therapeutic design. The complement anaphylatoxin receptor, C3aR is a potential drug target in various inflammatory disorders. Here, authors present insights into its activation, signaling, and pharmacology that is likely to facilitate therapeutic design going forward.

Nature Communications
University of Southern California (US), The University of Queensland (AU), Convergent Science (United States) (US), The University of Tokyo (JP), Indian Institute of Technology Kanpur (IN)
Arthritis National Research Foundation, University of Southern California, Japan Agency for Medical Research and Development, Indian Institute of Technology Kanpur, Department of Science and Technology, Ministry of Science and Technology, India, Indian Council of Medical Research, National Institutes of Health, Medical Research Council, National Health and Medical Research Council, Japan Society for the Promotion of Science, Science and Engineering Research Board
Zero hunger
Openalex Percentile: Top 16%
Complement system in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.